Table 2.
Adverse event profile summarized from multiple randomized controlled trials (derived from Wilt et al 2002)
| Adverse event | Tamsulosin | Placebo | Relative riska |
|---|---|---|---|
| Withdrawal – all cause | 12.2% | 12% | 1.02 (0.80–1.30) |
| Withdrawal – due to adverse event | 7.2% | 6.7% | 1.08 (0.72–1.62) |
| Headache | 14.3% | 14.6% | 1.00 (0.81–1.23) |
| Dizziness | 11.9% | 7.8% | 1.50 (1.13–1.98) |
| Rhinitis | 11.2% | 6% | 1.84 (1.24–2.72) |
| Abnormal ejaculation | 10.8% | <1% | 17.0 (2.5–114.2) |
| Asthenia | 6% | 4.3% | 1.33 (0.89–1.97) |
| Any adverse event | 53.5% | 51.3% | 1.07 (0.72–1.62) |
a
Relative risk is expressed as the calculated value with 95% confidence intervals in parentheses.